First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody (R)-CD3xCD20) in B-Cell Non-Hodgkin Lymphomas

Pieternella Lugtenburg; Rogier Mous; Michael Roost Clausen; Martine E. D. Chamuleau; Peter Johnson; Kim Linton; Simon Rule; Roberto S. Oliveri; Dena DeMarco; Ida H. Hiemstra; Guang Chen; Ada Azaryan; Manish Gupta; Tahamtan Ahmadi; Martin Hutchings

doi:10.1182/blood-2019-121460

First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody (R)-CD3xCD20) in B-Cell Non-Hodgkin Lymphomas

Pieternella Lugtenburg
, Rogier Mous
, Michael Roost Clausen
, Martine E. D. Chamuleau
, Peter Johnson
, Kim Linton
, Simon Rule
, Roberto S. Oliveri
, Dena DeMarco
, Ida H. Hiemstra
, Guang Chen
, Ada Azaryan
, Manish Gupta
, Tahamtan Ahmadi
, Martin Hutchings

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Blood
Volume	134
DOIs	https://doi.org/10.1182/blood-2019-121460
Publication status	Published - 13 Nov 2019

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2019-121460

Cite this

Lugtenburg, P., Mous, R., Clausen, M. R., Chamuleau, M. E. D., Johnson, P., Linton, K., Rule, S., Oliveri, R. S., DeMarco, D., Hiemstra, I. H., Chen, G., Azaryan, A., Gupta, M., Ahmadi, T., & Hutchings, M. (2019). First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody (R)-CD3xCD20) in B-Cell Non-Hodgkin Lymphomas. Blood, 134. https://doi.org/10.1182/blood-2019-121460

@article{a493e6c6d56747a78d1c1835bdb19428,

title = "First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody (R)-CD3xCD20) in B-Cell Non-Hodgkin Lymphomas",

author = "Pieternella Lugtenburg and Rogier Mous and Clausen, \{Michael Roost\} and Chamuleau, \{Martine E. D.\} and Peter Johnson and Kim Linton and Simon Rule and Oliveri, \{Roberto S.\} and Dena DeMarco and Hiemstra, \{Ida H.\} and Guang Chen and Ada Azaryan and Manish Gupta and Tahamtan Ahmadi and Martin Hutchings",

year = "2019",

month = nov,

day = "13",

doi = "10.1182/blood-2019-121460",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

}

Lugtenburg, P, Mous, R, Clausen, MR, Chamuleau, MED, Johnson, P, Linton, K, Rule, S, Oliveri, RS, DeMarco, D, Hiemstra, IH, Chen, G, Azaryan, A, Gupta, M, Ahmadi, T & Hutchings, M 2019, 'First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody (R)-CD3xCD20) in B-Cell Non-Hodgkin Lymphomas', Blood, vol. 134. https://doi.org/10.1182/blood-2019-121460

TY - JOUR

T1 - First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody (R)-CD3xCD20) in B-Cell Non-Hodgkin Lymphomas

AU - Lugtenburg, Pieternella

AU - Mous, Rogier

AU - Clausen, Michael Roost

AU - Chamuleau, Martine E. D.

AU - Johnson, Peter

AU - Linton, Kim

AU - Rule, Simon

AU - Oliveri, Roberto S.

AU - DeMarco, Dena

AU - Hiemstra, Ida H.

AU - Chen, Guang

AU - Azaryan, Ada

AU - Gupta, Manish

AU - Ahmadi, Tahamtan

AU - Hutchings, Martin

PY - 2019/11/13

Y1 - 2019/11/13

U2 - 10.1182/blood-2019-121460

DO - 10.1182/blood-2019-121460

M3 - Meeting Abstract

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

ER -